Inulin Market is estimated to be US$ 2.29 billion by 2030 with a CAGR of 5.5% during the forecast period

 


Inulin is a group of naturally occurring polysaccharide and is indigestible carbohydrate belonging to a class of fructans. Inulin has obtained the GRAS (generally recognize as safe) status in United States, due to which it is highly used in pharmaceutical industries. It consists of rich fiber and has very low calories. Inulin plays an important role in the growth of intestinal bacteria due to which it is also considered as dietary fiber.  Inulin is used as probiotic, due to its health benefits, especially to lower sugar and fat levels. The Global Inulin Market accounted for US$ 1.33 billion in 2020 and is estimated to be US$ 2.29 billion by 2030 and is anticipated to register a CAGR of 5.5%

The report "Global Inulin Market, By Application (Food and Beverage, Dietary Supplements, and Pharmaceutical) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”. Increasing awareness about prebiotic ingredients and their extensive utilization in food and beverages industry is the major factor driving the growth of the global inulin market globally. Inulin has various applications in dairy product formation such as cheese, yogurts, and ice-cream. Hence, the growth in dairy industries is projected to boost additional growth in inulin market over the forecast period. Also, high growth in the pharmaceuticals industry worldwide is propelling the growth of the target market. Furthermore, the fast-growing significance of nutraceuticals due to increasing health awareness is expected to increase demand for inulin as a functional ingredient.

Key Highlights:

·         In June 2018, Cosucra’s inulin-type fructans Fibruline extracted from chicory root has received regulatory approval from the U.S. Food and Drug Administration (FDA) for being listed as dietary fibres on the nutrition and supplement facts panel.

·         In June 2016, Sensus agreed to market organic inulin, sourced from agave, under its Frutafit line of products. Frutafit OAI is certified USDA organic and will help meet demand in the growing organic market.

Key Market Insights from the report:        

The Global Inulin Market accounted for US$ 1.33 billion in 2020 and is estimated to be US$ 2.29 billion by 2030 and is anticipated to register a CAGR of 5.5% . The market report has been segmented based on application and region.

·         By application, food and beverage segment accounts for the major share revue for the global market owing to the rise in the number of health-conscious consumers as it is considered as the powerhouse of fibre with low-calorie food

·         By region, Europe estimates for the highest market share in the global inulin market. Regulatory development aimed at supporting fortification of food with prebiotic ingredients is anticipated to drive inulin demand in the region.

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Inulin-Market-By-Application-403

The prominent player operating in the global inulin market includes Cargill Incorporated, Beneo-Orafti SA, CosucraGroupeWarcoing SA, Jarrow Formulas, Shandong Baolingbao Biotechnology Co. Ltd, SensusB.V, Fenchem, Inc, The Tierra Group, Ciranda, Inc, and Wuxi Cima Science Co. Ltd.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Humanized Liver Mice Model Market is estimated to be US$ 133.72 billion by 2030 with a CAGR of 5.30% during the forecast period

Image
Humanized Liver Mice Model Market   accounted for US$ 78.64 million in 2020 and is estimated to be US$ 133.72 million by 2030 and is anticipated to register a CAGR of 5.30%.  A lot of studies are underway to create novel humanized liver mouse models. Initially, liver mice models were created by implanting human liver cells or hepatic cancer cells into basic immune-deficient mice. The results, however, were inconsistent and unreliable. As a result, immune-deficient mice were developed, which spontaneously destroy the mice liver, allowing human liver cells to proliferate and replace it, resulting in stable humanized liver mice models. For example, a number of research projects are looking into using PPARalfa and AFC8-based mice models to develop humanized liver mice models. The report "Global Humanized Liver Mice Model Market, By Model (uPA-SCID, FRG KO Mice, TK-NOG Mice  and Other Models) By Application (Pharmacokinetics Studies, In-vivo Liver Toxicity Testing, Drug Metabolism Stud
Read more

Bipolar Disorder Market is estimated to be US$ 6.7 billion by 2030 with a CAGR of 2.3% during the forecast period

Image
Bipolar Disorder Market   accounted for US$ 5.3 billion in 2020 and is estimated to be US$ 6.7 billion by 2030 and is anticipated to register a CAGR of 2.3%. Bipolar disorder known as manic depression is a mental illness that brings low moods and severe high moods, thinking, changes in sleep and have periods in which they feel overly happy and energized and other side feel very sad, hopeless and sluggish. Bipolar disorder can cause severe disruption to a person’s life which can be treated with appropriate treatment and support. The report "   Global Bipolar Disorder Market, By Disorder (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder), By Drug Class (Mood Stabilizer, Anticonvulsant, Antipsychotic Drugs, Antidepressant Drugs, and Antianxiety Drugs), By Mechanism of Action (Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Beta Blockers, and Benzodiazepines), By Region (North
Read more

Monkeypox Disease Diagnostics Market - The abrupt global expansion of the monkeypox virus has increased the demand for monkeypox diagnostics.

Image
  The virus that causes smallpox and the Monkeypox both belong to the same family of viruses. Two outbreaks of a disease resembling the pox in groups of monkeys used for study led to the discovery of monkeypox in 1958. However, it has been observed in various parts of the world except Africa, where it is primarily found. It results in symptoms that resemble the flu, such as fever, chills, and a rash that might take weeks to go away. Even though instances of monkeypox are uncommon, they are growing in Africa and other areas where they have never before occurred. The fact that monkeypox is a rare disease may lead a healthcare provider to first rule out other rash infections, such measles or chickenpox. A tissue sample from an open sore is the first step in the medical professional's diagnosis of monkeypox (lesion). After that, send to a lab for PCR (Polymerase Chain Reaction). Additionally, blood is drawn to test for antibodies or the monkeypox virus. Currently, there is no licens
Read more